JP Morgan Private Wealth Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.85M | Buy |
+7,209
| New | +$1.93M | 0.01% | 765 |
|
|
2023
Q2 | – | Sell |
-11,353
| Closed | -$3.16M | – | 1523 |
|
|
2023
Q1 | $3.16M | Sell |
11,353
-153
| -1% | -$42.3K | 0.01% | 724 |
|
|
2022
Q4 | $3.19M | Buy |
11,506
+1,441
| +14% | +$407K | 0.01% | 700 |
|
|
2022
Q3 | $2.69M | Sell |
10,065
-1,810
| -15% | -$384K | 0.01% | 746 |
|
|
2022
Q2 | $2.42M | Sell |
11,875
-224
| -2% | -$45.8K | 0.01% | 782 |
|
|
2022
Q1 | $2.55M | Sell |
12,099
-41
| -0.3% | -$8.92K | 0.01% | 819 |
|
|
2021
Q4 | $2.91M | Sell |
12,140
-5,517
| -31% | -$1.42M | 0.01% | 780 |
|
|
2021
Q3 | $5M | Buy |
17,657
+6,293
| +55% | +$2.06M | 0.01% | 595 |
|
|
2021
Q2 | $3.94M | Sell |
11,364
-899
| -7% | -$272K | 0.01% | 651 |
|
|
2021
Q1 | $3.43M | Sell |
12,263
-1,246
| -9% | -$336K | 0.01% | 600 |
|
|
2020
Q4 | $3.31M | Sell |
13,509
-4,684
| -26% | -$1.21M | 0.01% | 587 |
|
|
2020
Q3 | $5.16M | Buy |
18,193
+4,001
| +28% | +$1.12M | 0.02% | 420 |
|
|
2020
Q2 | $3.8M | Sell |
14,192
-21
| -0.1% | -$6.31K | 0.02% | 422 |
|
|
2020
Q1 | $4.5M | Sell |
14,213
-1,693
| -11% | -$514K | 0.03% | 372 |
|
|
2019
Q4 | $4.72M | Sell |
15,906
-2,682
| -14% | -$744K | 0.02% | 433 |
|
|
2019
Q3 | $4.33M | Sell |
18,588
-3,877
| -17% | -$903K | 0.02% | 431 |
|
|
2019
Q2 | $5.25M | Sell |
22,465
-25,022
| -53% | -$5.78M | 0.03% | 377 |
|
|
2019
Q1 | $11.2M | Sell |
47,487
-14,870
| -24% | -$4.68M | 0.06% | 270 |
|
|
2018
Q4 | $18.8M | Buy |
62,357
+3,115
| +5% | +$994K | 0.11% | 179 |
|
|
2018
Q3 | $20.9M | Buy |
59,242
+6,005
| +11% | +$2.07M | 0.1% | 197 |
|
|
2018
Q2 | $15.5M | Buy |
53,237
+6,190
| +13% | +$1.74M | 0.09% | 218 |
|
|
2018
Q1 | $12.9M | Buy |
47,047
+3,905
| +9% | +$1.21M | 0.09% | 199 |
|
|
2017
Q4 | $13.7M | Sell |
43,142
-3,717
| -8% | -$1.19M | 0.09% | 198 |
|
|
2017
Q3 | $14.7M | Buy |
46,859
+2,215
| +5% | +$656K | 0.11% | 178 |
|
|
2017
Q2 | $12.1M | Sell |
44,644
-4,646
| -9% | -$1.23M | 0.09% | 189 |
|
|
2017
Q1 | $13.5M | Sell |
49,290
-1,679
| -3% | -$475K | 0.1% | 180 |
|
|
2016
Q4 | $14.5M | Sell |
50,969
-42,054
| -45% | -$12.5M | 0.13% | 165 |
|
|
2016
Q3 | $29.1M | Buy |
93,023
+34,904
| +60% | +$10.3M | 0.27% | 97 |
|
|
2016
Q2 | $14.1M | Buy |
58,119
+8,853
| +18% | +$2.33M | 0.14% | 150 |
|
|
2016
Q1 | $12.8M | Buy |
49,266
+13,609
| +38% | +$3.59M | 0.12% | 151 |
|
|
2015
Q4 | $10.9M | Buy |
35,657
+720
| +2% | +$207K | 0.11% | 171 |
|
|
2015
Q3 | $10.2M | Buy |
34,937
+13,416
| +62% | +$4.43M | 0.13% | 160 |
|
|
2015
Q2 | $8.69M | Buy |
21,521
+1,680
| +8% | +$674K | 0.1% | 202 |
|
|
2015
Q1 | $8.38M | Sell |
19,841
-204
| -1% | -$80.4K | 0.1% | 198 |
|
|
2014
Q4 | $6.8M | Buy |
20,045
+3,209
| +19% | +$1.04M | 0.08% | 219 |
|
|
2014
Q3 | $5.57M | Buy |
16,836
+3,043
| +22% | +$1M | 0.07% | 236 |
|
|
2014
Q2 | $4.35M | Buy |
13,793
+1,965
| +17% | +$591K | 0.07% | 213 |
|
|
2014
Q1 | $3.62M | Buy |
11,828
+5,203
| +79% | +$1.65M | 0.07% | 224 |
|
|
2013
Q4 | $1.85M | Buy |
6,625
+1,146
| +21% | +$296K | 0.04% | 257 |
|
|
2013
Q3 | $1.32M | Buy |
5,479
+141
| +3% | +$31.6K | 0.03% | 291 |
|
|
2013
Q2 | $1.15M | Buy |
+5,338
| New | +$1.14M | 0.03% | 302 |
|
Other funds holding BIIB
JP Morgan Private Wealth Advisors's BIIB Position: Q3 2023 in Review
JP Morgan Private Wealth Advisors opened a new position in Biogen (BIIB) in Q3 2023: 7,209 shares worth $1.85M. The stake represents 0.01% of the portfolio and ranks #765 among its holdings. This is a return to the name: JP Morgan Private Wealth Advisors previously reported a position in BIIB as recently as Q1 2023.
JP Morgan Private Wealth Advisors first reported a position in BIIB in Q2 2013 and has held it in 41 quarters since. The position peaked at $29.1M in Q3 2016. 966 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.
- JP Morgan Private Wealth Advisors held 7,209 shares of Biogen worth $1.85M as of Q3 2023.
- Biogen was a new JP Morgan Private Wealth Advisors position in Q3 2023.
- Biogen made up 0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #765 holding.
- JP Morgan Private Wealth Advisors first reported a position in Biogen in Q2 2013 and has held it in 41 quarters since.
- JP Morgan Private Wealth Advisors's Biogen position peaked at $29.1M in Q3 2016.
- 966 funds tracked by Wall St. Rank held Biogen as of Q3 2023.
Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.